biote Corp.

For the period ended Mar 31, 2026. Filed May 11, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 11, 2026

BTMD$1.08-2.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations and Comprehensive Income

(in thousands, except share and per share amounts) (Unaudited)

	Three Months Ended March 31,
	2026	2025
Revenue:
Product revenue	$43,895	$47,025
Service revenue	1,040	1,967
Total revenue	44,935	48,992
Cost of revenue
Cost of products	12,745	11,654
Cost of services	1,237	956
Cost of revenue	13,982	12,610
Selling, general and administrative	27,787	26,692
Income from operations	3,166	9,690
Other income (expense), net:
Interest expense, net	(1,972)	(2,905)
Gain from change in fair value of earnout liabilities	2,149	10,688
Other income (expense), net	(5)	(18)
Total other income (expense), net	172	7,765
Income before provision for income taxes	3,338	17,455
Income tax expense	662	1,616
Net income	2,676	15,839
Less: Net income attributable to noncontrolling interest	399	2,121
Net income attributable to biote Corp. stockholders	$2,277	$13,718
Other comprehensive income (loss):
Foreign currency translation adjustments	$2	$(4)
Other comprehensive income (loss)	2	(4)
Comprehensive income	$2,678	$15,835
Net income per common share
Basic	$0.07	$0.44
Diluted	$0.06	$0.37
Weighted average common shares outstanding
Basic	30,646,356	31,485,777
Diluted	35,995,490	36,952,961

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.